CD8A and cancer: The expression of ARPC5 was significantly associated with CD4+ T cell in 20 cancers, CD8+ T cell in 25 cancers, neutrophil cell in 32 cancers, macrophage cell in 27 cancers, and DC cell in 29 cancer types (Figure 6A).